Artesunate may inhibit liver fibrosis via the FAK/Akt/β-catenin pathway in LX-2 cells
Abstract Background An increasing number of studies are investigating the effects of Chinese medicine on hepatic fibrosis, but only few studies have examined the anti-fibrogenic properties of Artesunate (ART). The aim of the present study was to explore the anti-fibrotic effects of ART on LX-2 cells...
Saved in:
Main Authors: | Jian Lv (Author), Ruidan Bai (Author), Li Wang (Author), Jiefang Gao (Author), Hong Zhang (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2018-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Apigenin role against thioacetamide-triggered liver fibrosis: Deciphering the PPARγ/TGF-β1/NF-κB and the HIF/FAK/AKT pathways
by: Rehab Fawzy Abdel-Rahman, et al.
Published: (2023) -
Magnesium Isoglycyrrhizinate Ameliorates Fibrosis and Disrupts TGF-β-Mediated SMAD Pathway in Activated Hepatic Stellate Cell Line LX2
by: Jie Kai Tee, et al.
Published: (2018) -
AKT Inhibitor SC66 Inhibits Proliferation and Induces Apoptosis in Human Glioblastoma Through Down-Regulating AKT/β-Catenin Pathway
by: Lun Gao, et al.
Published: (2020) -
Advances in ultrasound-targeted microbubble-mediated gene therapy for liver fibrosis
by: Cuiyuan Huang, et al.
Published: (2017) -
Dec1 Deficiency Ameliorates Pulmonary Fibrosis Through the PI3K/AKT/GSK-3β/β-Catenin Integrated Signaling Pathway
by: Xingxing Hu, et al.
Published: (2022)